✨ Medicines Classification




NEW ZEALAND GAZETTE

No. 96

prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Emetine; and its salts; except in ipecacuanha and extracts and tinctures of ipecacuanha, and in medicines containing more than 0.05% of emetine

Ether; when used as a vehicle for a topical dose form

Fluorescein

Fluorides; in medicines for internal use containing 2.2 milligrams or less of fluoride per dosage unit; in medicines for external use containing fluoride in proportion equivalent to more than 0.1% of elemental fluorine

Folic acid; in medicines containing more than 500 mcg of folic acid per recommended daily dose

Glucagon

Guaiphenesin; in medicines containing more than 2% of guaiphenesin

Hetastarch

Hydrocortisone; and hydrocortisone acetate; in medicines for dermatological use containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container

Hydroquinone; in medicines containing more than 2% of hydroquinone

Ibuprofen; for external use

Idoxuridine; in medicines containing 0.5% or less of idoxuridine for dermatological use

Indomethacin; in medicines for external use containing 1% or less of indomethacin

Ipecacuanha

Jaborandi; alkaloids of; and their salts; in medicines containing 0.5% or more of the alkaloids of jaborandi

Ketoconazole; for dermatological use

Ketoprofen; and its salts; in medicines for external use

Lignocaine; and its salts; in medicines for external use containing more than 2% of lignocaine

Lobelia; alkaloids of; and their salts

Loratadine

Meclozine; and its salts; except in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Mefenamic acid; and its salts; in solid dose forms of 250 mg or less and in a pack containing not more than 20 tablets or capsules for the treatment of dysmenorrhoea

Mequitazine

Naproxen; and its salts; in solid dose forms containing the equivalent of 250 mg or less of naproxen per dose form, when in a pack containing not more than 20 tablets or capsules and sold for the treatment of dysmenorrhoea

Nicotine; in medicines for transdermal use

Noradrenaline; and its salts

Nystatin; in medicines for dermatological use

Oxerutins

Oxiconazole nitrate

Oxymetazoline; and its salts; for nasal use except when sold at an airport

Paracetamol; except where specified elsewhere in this notice

Pentastarch

Phenazone

Phenylephrine; for nasal use except when sold at an airport

Piroxicam; in medicines for external use containing 1% or less of piroxicam

Polygeline

Potassium chloride; except in medicines for oral rehydration therapy; except for use in haemodialysis concentrates and peritoneal dialysis solutions

Potassium citrate; except in medicines for oral rehydration therapy

Potassium perchlorate

Pramocaine; for external use in medicines containing more than 2%

Pregnancy test kits

Prilocaine; for external use in medicines containing more than 2%

Promethazine; and its salts; except promethazine theoclate in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Salicylic acid; and its salts; in medicines for external use containing more than 12.5% of salicylic acid

Selenium; and compounds of selenium; in medicines for external use containing more than 2.5% of selenium; and in medicines for internal use where the recommended daily dose exceeds 150 micrograms of selenium

Sennosides

Sodium cromoglycate; for nasal and ophthalmological use

Sulphadiazine; and its salts; in medicines for external use when in pack sizes containing 50 grams or less

Terbinafine; for external use

Thiomersal

Xylometazoline; and its salts; except for nasal use when sold at an airport

Yohimbe; alkaloids of; and their salts

Fourth Schedule

General Sale Medicines

Aconite; alkaloids of; and their salts; in medicines for external use containing less than 0.02% of the alkaloids of aconite

Adrenal extract; in dermatological medicines containing 0.02% or less of ketosteroids

Aescin; in medicines for external use

Aloes; in medicines for external use

Aluminium; and its salts; in medicines for external use

Aspirin; in enteric coated forms containing 300 mg or less per dose form

Barium sulphate

Benzocaine; for external use in medicines containing 2% or less; in throat lozenges containing 30 milligrams or less per dose form

Benzoyl peroxide; in medicines for external use containing 5% or less of benzoyl peroxide

Benzyl benzoate; in medicines containing 2.5% or less of benzyl benzoate

Beta carotene; in medicines containing 18 mg or less per recommended daily dose

Berberine

Bioallethrin; in medicines for external use

Butoxyethyl nicotinate

Cade oil; in medicines for external use

Calcium glucono-galacto-gluconate; except for parenteral use



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1995, No 96


NZLII PDF NZ Gazette 1995, No 96





✨ LLM interpretation of page content

πŸ₯ Classification of Medicines under the Medicines Act 1981 (continued from previous page)

πŸ₯ Health & Social Welfare
Medicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines, General Sale Medicines, Classification